Continuous infusion of Phenylephrine
ApprovedSmall molecule
Continuous infusion of Phenylephrine is one of 45 small molecule programs targeting Cesarean Section. It is currently in Approved.
1
Indications
1
Total Trials
1
Active Trials
44
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
230 competitors in Cesarean Section
#DrugCompanyPhaseTrials
1Continuous infusion of Phenylephrine
HHassan II University
Approved
Marcaine
IInnocoll
Preclinical
Pitocin
RRetrophin
Preclinical
Naropin
FFresenius Kabi Oncology Ltd.
Preclinical
Neo-Synephrine
EExela Pharma Sciences, LLC.
Preclinical
Dynastat
PfizerPreclinical
Duragesic
CCephalon
Preclinical
Catapres
Boehringer IngelheimPreclinical
Versed
CConrado Roberto Hoffmann Filho
Preclinical
Nubain
AAultman Health Foundation
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- HHassan II University